The Weekend Rip!
Presented by
The Weekend Rip
Happy Weekend!
Wall Street ended the week lower, with the S&P 500 down 0.6%, Nasdaq 100 off 1.6%, Russell 2000 losing 1%, and Dow slipping 0.4%. Oil surged 14% as attacks threatened shipping across the Middle East and Black Sea, pushing inflation and interest-rate concerns back into focus. Tesla and Alphabet reignited fears about runaway AI spending, the backlash spread to CoreWeave and Nebius, and Paramount’s Warner acquisition became more expensive as its court fight dragged on.
Let’s recap and prep you for the week ahead. 📝
Monday 🛢️: Stocks slipped as renewed U.S.-Iran fighting pushed oil and bond yields higher, smothering an early comeback in beaten-down AI names. IREN, AMD, and Alibaba gave traders fresh reasons to believe the AI trade still had legs, from cloud contracts to full-rack systems and a new Chinese model. Paramount-Warner supplied the day’s other cliffhanger after a federal judge froze the merger, setting up a week where war, courts, and Big Tech earnings all had a vote.
Tuesday 🧠: Stocks climbed as chipmakers and AI infrastructure names snapped back, pushing the Dow above 52,000. Supermicro’s margin surprise, SpaceX’s rebound, and fresh crypto legislation hopes gave traders plenty to chase. Crude’s +2.5% jump and two-month highs in Treasury yields kept the inflation warning light on.
Wednesday 🛢️: Stocks stalled as another oil spike and renewed Big Tech selling overpowered strength in energy and utilities. Tesla’s cash burn and Alphabet’s giant AI bill turned strong headline growth into a referendum on whether robots and cloud capacity can ever earn back the spending. OpenAI supplied the day’s strangest proof of concept after its cyber models escaped a sandbox and hacked Hugging Face to cheat on their own evaluation.
Thursday 🧾: Markets got hit with two enormous bills at once as oil crossed $100 and Tesla and Alphabet’s AI spending erased $500B in value. Trump widened tariff pressure to nearly all U.S. trade, while investors started cutting exposure to Amazon and Meta before their own spending updates. After hours, Intel finally found an AI lane through server demand, while Deckers proved an earnings beat does not help when HOKA and UGG are slowing.
Friday ☁️: Big Tech’s spending hangover spread down the AI supply chain, crushing neoclouds, chips, networking, and storage as investors braced for Amazon and Meta next week. Oil briefly offered relief after Pakistan revived hopes for U.S.-Iran talks, but attacks across Hormuz, the Red Sea, and the Black Sea kept $100 crude in the conversation. Paramount supplied another expensive clock after agreeing to delay its Warner takeover, with every extra quarter adding roughly $650M to the bill.
🤩 This week’s Stocktwits Top 25 showed how momentum movers fared vs. the indexes.
Here are the closing prices:
SPONSORED BY VIVANI MEDICAL
Vivani Medical Aims to Revolutionize Drug Delivery Starting with GLP-1s
Vivani Medical is rapidly advancing its SLIM-1 clinical trial of its lead asset, NPM-139, a miniature, ultra long-acting semaglutide implant designed to deliver steady, continuous therapy for months at a time. The first patient dosing in SLIM-1 is expected in August, a key upcoming milestone in the company’s mission to transform how chronic medications are delivered. This forward momentum builds upon other recent successes for the company, including Vivani’s new agreement with Novo Nordisk, announced in early July, allowing Novo Nordisk to evaluate its NanoPortal drug delivery technology.
*3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.
THE BRIEF
Need a concise summary of what’s going on this week? Look no further. Here’s a rundown of this week’s earnings and economic data.
Earnings This Week
Above is a quick summary. Check out the full Stocktwits earnings calendar for the other names reporting this week. And make sure to add your favorite earnings calls to your own Apple or Google Cal:
Economic Calendar
In addition to the above, check out this week’s complete list of economic releases.
SPONSORED BY INVESTOR’S BUSINESS DAILY
Turn off the business news and tune in to IBD Live.
See why 97% of subscribers say IBD Live has made them smarter investors. With IBD Live, you get:
A Commercial-Free Interactive Broadcast
Watch every morning as IBD’s analysts break down the first 90 minutes of market action.
New Trade Ideas Daily
Before the bell, our hosts highlight actionable stocks near buy points and watch for breakouts as the market opens.
Q&A Sessions with the Pros
Our team takes questions and stock suggestions from the audience and covers them live.
*3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.
ST EDITOR’S PICKS
Links That Don’t Suck 🌐
🤖 Why are investors freaking out about Big Tech’s booming AI capex?
📆 4 Big Tech earnings reports, a Fed meeting, and $100 oil: It’s the busiest week of the quarter
⚠️ Ukraine strikes Iranian vessels in Caspian Sea, Tehran accuses Kyiv of ‘hostile and criminal act’
💣️ US strikes ‘on a hold,’ as talks, battle for Strait of Hormuz control loom with Iran
🧑🚒 More than 360,000 evacuated as wildfires rage in France and Spain
Get In Touch 📬
Want to see some change? Email Kevin Travers your feedback; follow him on Stocktwits.
Terms & Conditions 📝
Securities Disclaimer: STOCKTWITS IS NOT A TAX ADVISOR, BROKER, FINANCIAL ADVISOR OR INVESTMENT ADVISOR. THE SERVICE IS NOT INTENDED TO PROVIDE TAX, LEGAL, FINANCIAL OR INVESTMENT ADVICE, AND NOTHING ON THE SERVICE SHOULD BE CONSTRUED AS AN OFFER TO SELL, A SOLICITATION OF AN OFFER TO BUY, OR A RECOMMENDATION FOR ANY SECURITY. Trading in such securities can result in immediate and substantial losses of the capital invested. You should only invest risk capital, and not capital required for other purposes. You alone are solely responsible for determining whether any investment, security or strategy, or any other product or service, is appropriate or suitable for you based on your investment objectives and personal and financial situation. You should also consult an attorney or tax professional regarding your specific legal or tax situation. The Content is to be used for informational and entertainment purposes only and the Service does not provide investment advice for any individual. Stocktwits, its affiliates and partners specifically disclaim any and all liability or loss arising out of any action taken in reliance on Content, including but not limited to market value or other loss on the sale or purchase of any company, property, product, service, security, instrument, or any other matter. You understand that an investment in any security is subject to a number of risks, and that discussions of any security published on the Service will not contain a list or description of relevant risk factors. In addition, please note that some of the stocks about which Content is published on the Service have a low market capitalization and/or insufficient public float. Such stocks are subject to more risk than stocks of larger companies, including greater volatility, lower liquidity and less publicly available information. Read the full terms & conditions here. 🔍
Author Disclosure: The author of this newsletter does not hold positions in any of the securities or assets mentioned. 📋
